Sanders Morris Harris’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sanders Morris Harris’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-668,000	Closed	-$165K	–	249
2026 Q1	$165K	Buy	+668,000	New	+$266K	0.03%	269
2025 Q4	–	Sell	-303,000	Closed	-$204K	–	257
2025 Q3	$204K	Buy	303,000 +114,500	+61%	+$61.7K	0.03%	274
2025 Q2	$102K	Buy	+188,500	New	+$112K	0.02%	155

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Sanders Morris Harris's SGMO Position: Q2 2026 in Review

Sanders Morris Harris sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 668,000 shares — an estimated $165K sold.

Sanders Morris Harris first reported a position in SGMO in Q2 2025 and held it in 3 quarters. The position peaked at $204K in Q3 2025. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Sanders Morris Harris reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Sanders Morris Harris sold 668,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $165K.
Sanders Morris Harris first reported a position in SANGAMO THERAPEUTICS INC in Q2 2025 and held it in 3 quarters.
Sanders Morris Harris's SANGAMO THERAPEUTICS INC position peaked at $204K in Q3 2025.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.